会员体验
专利管家(专利管理)
工作空间(专利管理)
风险监控(情报监控)
数据分析(专利分析)
侵权分析(诉讼无效)
联系我们
交流群
官方交流:
QQ群: 891211   
微信请扫码    >>>
现在联系顾问~
热词
    • 2. 发明授权
    • Microparticle compositions and methods for the manufacture thereof
    • 微粒组合物及其制造方法
    • US07846479B2
    • 2010-12-07
    • US10775964
    • 2004-02-10
    • Jia-Hwa FangManmohan SinghDerek O'HaganManinder Hora
    • Jia-Hwa FangManmohan SinghDerek O'HaganManinder Hora
    • A61K9/14
    • A61K9/1676A61K9/1647
    • Microparticles with adsorbed complexes of macromolecule and detergent, methods of making such microparticles, and uses thereof, are disclosed. The microparticles comprise a polymer, such as a poly(α-hydroxy acid), a polyhydroxy butyric acid, a polycaprolactone, a polyorthoester, a polyanhydride, and the like, and are formed using cationic, anionic, or nonionic detergents. The surfaces of the microparticles have adsorbed thereon a complex of biologically active macromolecules, such as nucleic acids, polypeptides, antigens, and adjuvants, and a detergent. Preferred polymers are poly(D,L-lactide-co-glycolides), more preferably those having a lactide/glycolide molar ratio ranging from 40:60 to 60:40 and having a molecular weight ranging from 30,000 Daltons to 70,000 Daltons. Preferred macromolecules are bacterial and viral antigens (such as HIV antigens, meningitis B antigens, streptococcus B antigens, and Influenza A hemagglutinin antigens) as well as polynucleotides that encode for such antigens.
    • 公开了具有大分子和洗涤剂的吸附复合物的微粒,制备这种微粒的方法及其用途。 微粒包含聚(α-羟基酸),多羟基丁酸,聚己内酯,聚原酸酯,聚酐等聚合物,并使用阳离子,阴离子或非离子型洗涤剂形成。 微粒表面上吸附有生物活性大分子如核酸,多肽,抗原和佐剂以及洗涤剂的复合物。 优选的聚合物是聚(D,L-丙交酯 - 共 - 乙交酯),更优选丙交酯/乙交酯摩尔比范围为40:60至60:40且分子量范围为30,000道尔顿至70,000道尔顿的聚合物。 优选的大分子是细菌和病毒抗原(例如HIV抗原,脑膜炎B抗原,B链球菌抗原和甲型流感血凝素抗原)以及编码这些抗原的多核苷酸。
    • 8. 发明授权
    • Compositions for inducing immune responses
    • 用于诱导免疫反应的组合物
    • US07731967B2
    • 2010-06-08
    • US10837117
    • 2004-04-29
    • Derek O'HaganManmohan Singh
    • Derek O'HaganManmohan Singh
    • A61K39/00
    • A61K39/39A61K2039/55511A61K2039/55555
    • The invention provides, inter alia, immunogenic compositions comprising a first antigen, at least two adjuvants, wherein a first adjuvant comprises a polymer derived from poly(lactides) and/or poly(lactide-co-glycolides), and wherein a second adjuvant comprises an imidazoquinoline, wherein said first antigen is encapsulated within, adsorbed or conjugated to, co-lyophilized or mixed with said first adjuvant, and a pharmaceutically acceptable excipient, wherein said composition elicits a cellular immune response when administered to a vertebrate subject. The invention also provides methods of producing immunogenic compositions, methods for producing a cytotoxic-T lymphocyte (CTL) response in a vertebrate subject, and methods of immunization.
    • 本发明尤其提供包含第一抗原,至少两种佐剂的免疫原性组合物,其中第一佐剂包含衍生自聚(丙交酯)和/或聚(丙交酯 - 共 - 乙交酯)的聚合物,并且其中第二佐剂包含 咪唑并喹啉,其中所述第一抗原包被在所述第一佐剂中并被共冻干或混合,吸附或缀合,以及药学上可接受的赋形剂,其中所述组合物在施用于脊椎动物受试者时引起细胞免疫应答。 本发明还提供产生免疫原性组合物的方法,在脊椎动物受试者中产生细胞毒性T淋巴细胞(CTL)应答的方法和免疫方法。